237 related articles for article (PubMed ID: 34438161)
1. Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.
Wang T; Zhou Y; Zhou R; Huang W; Wang J; Li H; Lei M; Tan X; Zhang Y
Stem Cell Res; 2021 Oct; 56():102509. PubMed ID: 34438161
[TBL] [Abstract][Full Text] [Related]
2. Generation of three iPSC lines (XACHi007-A, XACHi008-A, XACHi009-A) from a Chinese family with long QT syndrome type 5 with heterozygous c.226G>A (p.D76N) mutation in KCNE1gene.
Zhang Y; Li H; Wang J; Wang G; Tan X; Lei M
Stem Cell Res; 2020 May; 45():101798. PubMed ID: 32344329
[TBL] [Abstract][Full Text] [Related]
3. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
Zhang Y; Li A; Huang CL; Wang G; Wang D
Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
[TBL] [Abstract][Full Text] [Related]
5. Establishment of iPSC line from a Chinese infant (XACHi012-A) with Jervell and Lange-Nielsen syndrome carrying combined KCNQ1 frameshift c.431delC(p.I145Sfs*92) and nonsense c.1175G > A (p.W392X) variants and two iPSC lines from the parents (XACHi013-A, XACHi014-A).
Zhou Y; Wang J; Li H; Li A; Wang G; Tan X; Lei M; Zhang Y
Stem Cell Res; 2021 May; 53():102391. PubMed ID: 34088017
[TBL] [Abstract][Full Text] [Related]
6. Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).
Wang B; Ren Q; Cui X; Shan W; Guo X; Wang X; Wang J; Li Y; An G
Stem Cell Res; 2024 Jun; 77():103400. PubMed ID: 38547667
[TBL] [Abstract][Full Text] [Related]
7. Generation of two induced pluripotent stem cell lines (XACHi0010-A, XACHi0011-A) from a Chinese family with combined oxidative phosphorylation deficiency carrying homozygous and heterozygous C1QBP-L275F mutation.
Zhang Y; Wang J; Zhou Y; Li H; Li A; Tan X; Wang G; Lei M
Stem Cell Res; 2020 Jul; 47():101912. PubMed ID: 32707487
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene.
Zhang Y; Li A; Wang J; Wang G; Wang D
Stem Cell Res; 2019 Dec; 41():101621. PubMed ID: 31743840
[TBL] [Abstract][Full Text] [Related]
9. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.
Zhao J; Wang L; Zhu K; Chen X; Qin F; Li X; Dong J; Tao H
Stem Cell Res; 2022 Aug; 63():102836. PubMed ID: 35700634
[TBL] [Abstract][Full Text] [Related]
10. Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.
Guo F; Sun Y; Wang H; Wang H; Zhou J; Fan H; Su J; Gong T; Jiang C; Liang P
Stem Cell Res; 2022 Jul; 62():102813. PubMed ID: 35569348
[TBL] [Abstract][Full Text] [Related]
11. Derivation and characterization of two human induced pluripotent stem cell lines (NUIGi004-A) and (NUIGi012-A) from two patients with LQT2 disease.
Liu M; Ge N; Zhang J; Yang M; Yang F; Krawczyk J; Ward D; McInerney V; O'Brien T; Shen S; Prendiville T
Stem Cell Res; 2021 Oct; 56():102555. PubMed ID: 34628246
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
[TBL] [Abstract][Full Text] [Related]
13. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
Ross SB; Fraser ST; Bagnall RD; Semsarian C
Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells (SHCDNi002-A cells) isolated from the peripheral blood mononuclear cells of a 1-year-old Chinese girl with mediator complex subunit 12-related syndrome.
Wang Y; Yuan F; Wang A; Wang C; Lin L; Wang S; Wang C; Luo X; Xu Q; Yin R; Cheng H; Zhang Y; Sun X; Xi J; Yan J; Zeng F; Chen Y
Stem Cell Res; 2020 Jul; 46():101838. PubMed ID: 32505899
[TBL] [Abstract][Full Text] [Related]
16. R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome.
Mesquita FCP; Arantes PC; Kasai-Brunswick TH; Araujo DS; Gubert F; Monnerat G; Silva Dos Santos D; Neiman G; Leitão IC; Barbosa RAQ; Coutinho JL; Vaz IM; Dos Santos MN; Borgonovo T; Cruz FES; Miriuka S; Medei EH; Campos de Carvalho AC; Carvalho AB
Sci Rep; 2019 Dec; 9(1):19203. PubMed ID: 31844156
[TBL] [Abstract][Full Text] [Related]
17. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
20. Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation.
Tian Y; Shi Z; Liao Y; Cai J; Li W; Li X; Chen WX
Stem Cell Res; 2022 Apr; 60():102667. PubMed ID: 35066241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
